Lenalidomide network is enriched in several essential pathways such as PI3K-Akt, ErbB, MAPK, Ras, Rap1, VEGF, and FoxO signaling pathways, while the I-BET-762 network is enriched in Jak-STAT signaling and transcriptional misregulation in cancer pathways (Fig. 4b). The gene discussed is EGFR; the disease is cancer.